Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease: A Pilot Study

NCT05364684 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT05364684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05364684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease: A Pilot Study
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
August 10, 2022
Completion date
December 23, 2024
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nafld, nash - nonalcoholic steatohepatitis, nonalcoholic fatty liver